自我实验的自我实验

Same author

Survival trends, coronary event rates, and the MONICA project. Monitoring trends and determinants in cardiovascular disease.

Lancet (London, England)·1999

Same author

Do dietary lectins cause disease?

BMJ (Clinical research ed.)·1999

Same author

Headache and Chiari I malformation in the pediatric population.

Pediatric neurosurgery·1998

Same author

On arterial calcification.

International journal of cardiology·1998

Same author

Little arrows.

Lancet (London, England)·1996

Same author

Food antibodies in acute psychoses.

Psychological medicine·1985

Same journal

Assisted dying and the silencing of medicine's next generation.

Lancet (London, England)·2026

Same journal

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Lancet (London, England)·2026

Same journal

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

Lancet (London, England)·2026

Same journal

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Lancet (London, England)·2026

Same journal

Research priorities for characterising Bundibugyo virus.

Lancet (London, England)·2026

Same journal

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

Lancet (London, England)·2026

相关实验视频

自我实验的自我实验

相关概念视频

Survival trends, coronary event rates, and the MONICA project. Monitoring trends and determinants in cardiovascular disease.

Do dietary lectins cause disease?

Headache and Chiari I malformation in the pediatric population.

On arterial calcification.

Little arrows.

Food antibodies in acute psychoses.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.

相关实验视频

自我实验的自我实验

相关概念视频

相关文章

Survival trends, coronary event rates, and the MONICA project. Monitoring trends and determinants in cardiovascular disease.

Do dietary lectins cause disease?

Headache and Chiari I malformation in the pediatric population.

On arterial calcification.

Little arrows.

Food antibodies in acute psychoses.

Assisted dying and the silencing of medicine's next generation.

Linguistic pragmatism: a woman with progressive abdominal pain in Thailand.

Medical compartmentalisation: a patient with chromosome 22q11.2 deletion syndrome in Japan.

[<sup>177</sup>Lu]Lu-edotreotide versus everolimus for gastroenteropancreatic neuroendocrine tumours (COMPETE): a phase 3, multicentre, randomised, open-label, superiority trial.

Research priorities for characterising Bundibugyo virus.

Rethinking treatment sequence in advanced gastroenteropancreatic neuroendocrine tumours.